Status:
UNKNOWN
The Efficacy Of Lidocaine Infusion IN Chronic Unilateral Migraine Headache
Lead Sponsor:
Alexandria University
Conditions:
Chronic Migraine, Headache
Eligibility:
All Genders
18-55 years
Phase:
PHASE2
Brief Summary
STUDY THE EFFICACY OF INTRAVENOUS LIDOCAINE INFUSION ON PATIENTS WITH CHRONICUNILATERAL MIGRAINE HEADACHE ..NO OF PATIENTS 80..WILLBE DIVIDED INTO 2 GROUPS..FIRST WILL RECEIVE MEDICAL TREATMENT PLUS L...
Detailed Description
Group A will receive medical treatment for migraine plus normal saline infusion,Group B will receive medical treatment plus lidocaine infusion at dose from 3 to 4 mg per kg,computer generated random n...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age (18-55) years for both genders.
- Patients with chronic unilateral migraine headache for at least (3) month with VASscore more than (4).
- Patient who failed to respond to conservative treatment as medical treatment algorithm including at least tow preventive trials.
- Excusion criteria:
- patient with disabling chronic disease or psychiatric illness
- unstable cardiac arrhythmia
- patient refusal red flags
Exclusion
Key Trial Info
Start Date :
October 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06109389
Start Date
October 1 2023
End Date
June 1 2024
Last Update
October 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria University,Medical Research Institute
Alexandria, Egypt, 5310002